CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 409 filers reported holding CRISPR THERAPEUTICS AG in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $353,180 | -29.3% | 7,781 | -12.6% | 0.01% | -66.7% |
| Q2 2023 | $499,814 | +11.8% | 8,903 | -9.9% | 0.04% | +5.9% |
| Q1 2023 | $446,912 | +17.8% | 9,880 | +5.8% | 0.03% | +9.7% |
| Q4 2022 | $379,427 | -52.2% | 9,334 | -23.2% | 0.03% | -58.7% |
| Q3 2022 | $794,000 | -7.2% | 12,149 | -13.7% | 0.08% | -5.1% |
| Q2 2022 | $856,000 | +5.5% | 14,078 | +9.0% | 0.08% | +25.4% |
| Q1 2022 | $811,000 | -33.0% | 12,919 | -19.2% | 0.06% | -28.4% |
| Q4 2021 | $1,211,000 | – | 15,987 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $27,989,046 | 33.20% |
| Gilfoyle Management LLC | 100 | $4,842 | 15.90% |
| NEA Management Company, LLC | 1,587,854 | $89,142,124 | 6.80% |
| ARK Investment Management | 7,338,447 | $411,980,394 | 2.73% |
| Nikko Asset Management Americas, Inc. | 3,533,357 | $198,327,328 | 2.09% |
| Del-Sette Capital Management, LLC | 33,661 | $1,889,729 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Merlin Capital, Inc | 8,802 | $494,144 | 1.67% |
| Green Alpha Advisors, LLC | 34,373 | $1,929,700 | 1.27% |